David H. Peyton
Corporate Officer/Principal presso Portland State University
Posizioni attive di David H. Peyton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Portland State University | Corporate Officer/Principal | 30/10/2009 | - |
Storia della carriera di David H. Peyton
Precedenti posizioni note di David H. Peyton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
DesignMedix, Inc.
 DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Fondatore | 01/01/2006 | - |
Formazione di David H. Peyton
| Abilene Christian University | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
DesignMedix, Inc.
DesignMedix, Inc. Pharmaceuticals: MajorHealth Technology DesignMedix, Inc. develops drugs to overcome drug-resistant diseases. Its pipeline includes RCQ anti-malaria drugs, modified acridone and anti-bacterial drugs. The firm is a drug development company, which develops drugs to overcome drug resistance with a focus on curing malaria in Oregon. It develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. The company was founded by Sandra Lee Shotwell, David H. Peyton and Lynnor B. Stevenson in 2006 and is headquartered in Portland, OR. | Health Technology |
- Borsa valori
- Insiders
- David H. Peyton
- Esperienza
